← BackCOOPER COMPANIES, INC. · Ophthalmic GoodsCOO
Low riskNext report: Around Dec 3 (est.)
The short versionA profitable company with steady sales. Institutions are adding.
Going well
- Profitable every year for 10 years
- Brings in more cash than it spends
- Little debt
Money moves
- No insider buying or selling in the last 30 days
- Institutions added 2.1% to their holdings in the quarter ending June 2026 (360 bought, 337 sold)
- Held by Ray Dalio (Bridgewater)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$61.14-0.1% that day
- Company value
- $11.6B
- Share price times all shares
- Price vs profit (P/E)
- 20.9x
- You pay about $21 for each $1 of yearly profit
- Price vs sales
- 2.7x
- Company value is 2.7 times a year of sales
- Cash vs value
- 1%
- Cash as a share of company value
- Debt vs value
- 16%
- Debt as a share of company value
From COO's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jul '26$1.1B+0.6% vs a year earlier
Oct '23Tap a barJul '26
Last 12 months: $4.2B, up 4.7% from the 12 months before. Over 5 years, sales grew about 11% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.4.5%
- PassDebt under half of equityNot relying on borrowed money.0.22x equity
- MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.9.2%
- PassProfitable every yearSteady profits, not one good year.10 of 10 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$433.7M
- PassShare count not growingNot diluting owners. Falling means buybacks.+0.6% in 3 years
- PassGross margin 40%+Pricing power: sells for well above what it costs to make.65.5%
- Revenue
- $4.1B
- +5.1% vs prior year
- 5-year growth
- +11.0%/yr
- revenue, per year
- Total debt
- $1.9B
- 0.22x equity
- Current ratio
- 1.34x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jul 31, 2026- Revenue
- $1.1B
- +0.6% YoY
- EPS
- $2.24
- vs $0.49
- Op. margin
- 20.8%
- +4.2 pts
- Gross margin
- 66.8%
- +1.5 pts
- Free cash flow
- $273.0M
- Share count
- -3.3%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 1
- Normal week
- 0.5
- vs normal
- 2.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
▲Accumulating+2.1%Institutions added 2.1% to their holdings. 360 bought, 337 sold.
Shares held by institutions209.8M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
-1.3%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
0.2x · $1.9B debtShares outstandingLatest reported
190MNext reportAround Dec 3 (est.)Estimated from the same quarter last year
- Results filedSep 9
- Results filedJun 4
- Results filedMar 5
- Results filedDec 4, 2025
- Results filedAug 27, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days
No offerings, red flags or new big holders. Clean record.
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Latest filings
Straight from SEC EDGAR
BoughtLawrence Erik KurziusDirector
10,000 shares at $54.93 · $549K
- +47% of holdings
- Now owns 31,099 shares
- Filed 1 day after trade
BoughtPaul A KeelDirector
4,701 shares at $53.18 · $250K
- New position
- Now owns 4,701 shares
- Filed 4 days after trade
BoughtLawrence Erik KurziusDirector
10,000 shares at $53.92 · $539K
- +90% of holdings
- Now owns 21,099 shares
- Filed 1 day after trade
BoughtWalter M Jr RosebroughDirector
10,000 shares at $54.16 avg ($54.11 to $54.29) · $542K
- +100% of holdings
- Now owns 20,000 shares
- Held see footnote
- 2 transactions
- Filed 1 day after trade
Stock awardPaul A KeelDirector
2,814 shares
- Now owns 2,814 shares
- Restricted Stock Units
- Filed 5 days after trade